InvestorsHub Logo

furbush87

09/19/14 3:46 PM

#22395 RE: cameron12x #22393

I like all your numbers except "no partner go it alone" I think that would warrant .60-.70.
From what I can tell ONCS is just slightly on discount right now. .65-.75 is a more appropriate price for the stage and potential. Its obvious ONCS was a bit over priced running into ASCO with the belief final data and partnership was right around the corner. After reality set in, a massive over done sell off. We get final P2 data we should be back in around .80 barring cold feet or negative news.
Time will tell